He, Hailong
Karlas, Angelos
Fasoula, Nikolina-Alexia
Fischer, Chiara
Darsow, Ulf
Kallmayer, Michael
Aguirre, Juan
Eckstein, Hans-Henning
Ntziachristos, Vasilis https://orcid.org/0000-0002-9988-0233
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (No 871763 (WINTHER))
EC | Horizon 2020 Framework Programme (No 687866 (INNODERM))
EC | Horizon 2020 Framework Programme (No 694968 (PREMSOT))
EC | Horizon 2020 Framework Programme (No 862811 (RSENSE))
EC | Horizon 2020 Framework Programme (No 101017802 (OPTOMICS))
Helmholtz Association (Initiative and Networking Fund i3 (ExNet-0022-Phase2-3))
Helmholtz Association (Initiative and Networking Fund, i3 (ExNet-0022-Phase2-3))
Helmholtz Association (Physician Scientists for Groundbreaking Projects)
DZHK
Helmholtz Initiative and Networking Fund (Impuls- und Vernetzungsfonds der Helmholtz-Gemeinschaft)
Article History
Received: 22 January 2025
Revised: 19 September 2025
Accepted: 15 October 2025
First Online: 3 January 2026
Conflict of interest
: V.N. is a founder and equity owner of Maurus OY, sThesis GmbH, iThera Medical GmbH, Spear UG and I3 Inc. The remaining authors declare no competing interests.